Alpstein Biotech · Tissue engineering and bioprinting
Alpstein Biotech
Collagen applications by sector All applications and the format matrix
{{ megaImg }}
{{ megaCap }}

Collagen for tissue engineering and bioprinting

In a tissue engineering lab, collagen is the variable nobody wants. The cells are the experiment. The collagen is meant to be the constant, the surface everything else is measured against. When a new lot gels at a different rate, or the gel sits softer than the last one, three weeks of differentiation data becomes hard to compare and the team is troubleshooting the substrate instead of the science.

Placeholder · direction: Confocal · cells on a collagen matrix
~300 kDaintact triple helix
<1%non-collagen protein
Soluble and insolublefrom one specification
01

What we supply

Bioprinting sharpens the problem further. A bioink has to move through a nozzle without shearing the cells, hold its shape the moment it lands, and crosslink on a schedule the print head can rely on. All of that follows from molecular weight distribution and fibril forming behaviour, which follow from how the collagen was extracted.

Alpstein supplies both sides of the material in one specification. Soluble atelocollagen, as solution or powder, for bioinks, hydrogels, surface coatings and self assembling fibrillar gels. Insoluble fibrous atelocollagen, as paste, sheet or powder, for freeze dried porous scaffolds, mechanically loaded constructs and anything that has to hold geometry in culture for weeks. Sterile grades for work that goes anywhere near a clinical route, non sterile for bench development.

The material ends up in printed skin, cartilage and vascular constructs, organ on chip matrices, 3D disease and tumour models, stem cell differentiation platforms, cell laden hydrogels for delivery studies, and freeze dried scaffolds seeded for regeneration work. It also ends up in the quiet places that decide whether an experiment works, coating plates and microcarriers, forming the interface between a synthetic scaffold and the cells expected to colonise it.

Forms and options
Placeholder · direction: Bioprinter nozzle mid extrusion
Placeholder · direction: Hydrogel in a well plate, backlit

Your cells are the experiment. The matrix should not be.

Placeholder · direction: Collagen solution drawn into a pipette
02

What Alpstein brings to the build

01

The triple helix arrives intact, at approximately 300 kDa. Self assembly into fibrils behaves the way the literature says it should, so gelation time, fibril diameter and final stiffness are properties you can set rather than observe.

02

Telopeptides are removed. Lower immunogenicity matters for any construct with a translational future, and it removes one variable from long culture.

03

Fragment length is defined across multiple centrifuge stations in a closed process, which is what makes viscosity, and therefore printability, repeatable between lots. A print profile tuned in March still runs in September.

04

Total protein above 98 percent, non-collagen protein below 1 percent and endotoxin below 0.5 EU per mL keep the background clean. In primary cell and stem cell work, endotoxin is the difference between a real result and a slow inflammatory artefact.

05

Independent characterisation comes from Intertek for purity and identity, with mechanical properties tested at Cambridge and Oxford. For a group publishing on a scaffold, third party data on the substrate strengthens the method section.

06

Volumes suit the way this work actually runs. Small quantities for method development, then the same material, same specification, when the protocol scales to a production batch or a partner’s facility.

03

Why Alpstein

Native fibril self assembly, so gelation and stiffness are controllable parameters.

Intact triple helix.

Lower immunogenicity for constructs with a clinical destination, and one less variable in long culture.

Atelopeptide.

Print settings hold, so a nozzle profile does not need retuning with every delivery.

Repeatable viscosity between lots.

Bioink and load bearing scaffold sourced from the same qualified material.

Soluble and insoluble grades side by side.

Clean background for primary cells, stem cells and immunological readouts.

Endotoxin below 0.5 EU/mL.

Porous scaffolds with pore structure that follows from the collagen, not from luck.

Freeze drying ready.

EDC, genipin and photochemical routes all start from a known substrate.

Compatible with common crosslinking chemistries.

A protocol developed at the bench can move toward a clinical route without changing supplier.

Sterile grade available.

Strengthens a method section and a partner’s due diligence at the same time.

Independent purity and mechanical data.

The material that worked in development is the material that scales.

Gram to kilogram supply.

A print profile tuned in March still runs in September.
Placeholder · direction: Freeze dried scaffold cross section
Gelation you can set, rather than gelation you discover.
Placeholder · direction: Printed lattice held with forceps

Clean background, or you are measuring the endotoxin.

Talk to the team about your application.

Request a specification packNext · Pharma and drug delivery